article thumbnail

Postural Sway Velocity Effective for Assessing Diabetic Peripheral Neuropathy

Physician's Weekly

Postural sway velocity as a screening tool in diabetic peripheral neuropathy represents a potential early marker of balance impairment and fall risk. The 2025 annual meeting of the Peripheral Nerve Society (PNS) took place in Edinburgh, Scotland, from May 17, 2025 to May 20, 2025.

article thumbnail

ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water

Physician's Weekly

WEDNESDAY, June 25, 2025 (HealthDay News) — For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss and T2D remission, according to a study presented at the annual meeting of the American Diabetes Association, held from June 20 to 23 in Chicago.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. More Information Copyright © 2025 HealthDay.

article thumbnail

What to Expect at the ADA 85th Scientific Sessions: Obesity, Nutrition, Prevention, and More

Physician's Weekly

The ADA’s 85th Scientific Sessions will highlight breakthroughs in obesity and diabetes care, including GLP-1 therapies, tech advances, and prevention tools. In fact, obesity is linked to 30–53% of new diabetes cases in the US yearly and continues to rise.” Roughly 42% (109.9

article thumbnail

Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics , a gene-editing startup, for about $1 billion upfront. That payout would happen if the first patient receives the treatment within 10 years of the deal closing. The deal, announced June 17, includes a cash offer of $10.50

article thumbnail

Redesigning Primary Care Workflows to Optimize Obesity Management

Physician's Weekly

The PATHWEIGH trial aims to embed structured obesity care into primary care, addressing barriers and boosting clinician confidence and patient outcomes. Through this model, PATHWEIGH seeks to improve both the clinical delivery of weight management services and patient outcomes.

article thumbnail

Maria Ansari, MD, FACC, named to Modern Healthcare’s list of 50 Most Influential Clinical Executives

Permanente Medicine

June 10, 2025) — Maria Ansari, MD, FACC , co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare’s list of 50 Most Influential Clinical Executives for 2025. The result is high-quality, high-value care within an integrated system — improving lives and shaping the future of health care.”

Clinic 59